These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. IFN-gamma, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10/4 Trypanosoma cruzi parasites. Marinho CR; Nuñez-Apaza LN; Martins-Santos R; Bastos KR; Bombeiro AL; Bucci DZ; Sardinha LR; Lima MR; Alvarez JM Scand J Immunol; 2007; 66(2-3):297-308. PubMed ID: 17635807 [TBL] [Abstract][Full Text] [Related]
7. [Myocardial cellular damage and the activity of the mitochondrial ATP synthase in rats infected with a Colombian strain of Trypanosoma cruzi]. Rendón DA; Genes CM; Triana O Biomedica; 2007 Jan; 27 Suppl 1():40-9. PubMed ID: 18154244 [TBL] [Abstract][Full Text] [Related]
8. [Characterization of Trypanosoma cruzi strains isolated from patients with heart transplantation]. Lahura PN; Matsubara L; Amato Neto V; Okumura M; Bocchi EA Rev Hosp Clin Fac Med Sao Paulo; 1995; 50(2):97-100. PubMed ID: 7569603 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of neural cell adhesion molecule in Chagas' myocarditis. Soler AP; Gilliard G; Xiong Y; Knudsen KA; Martin JL; De Suarez CB; Mota Gamboa JD; Mosca W; Zoppi LB Hum Pathol; 2001 Feb; 32(2):149-55. PubMed ID: 11230701 [TBL] [Abstract][Full Text] [Related]
10. [Chagas disease. Importance of the parasite in the pathogenesis of the cardiac chronic disease]. Higuchi ML Arq Bras Cardiol; 1995 Mar; 64(3):251-4. PubMed ID: 7487514 [No Abstract] [Full Text] [Related]
11. Characterization of cardiopulmonary function and cardiac muscarinic and adrenergic receptor density adaptation in C57BL/6 mice with chronic Trypanosoma cruzi infection. Rocha NN; Garcia S; Giménez LE; Hernández CC; Senra JF; Lima RS; Cyrino F; Bouskela E; Soares MB; Ribeiro dos Santos R; Campos de Carvalho AC Parasitology; 2006 Dec; 133(Pt 6):729-37. PubMed ID: 16978452 [TBL] [Abstract][Full Text] [Related]
12. Modification of the pattern of infection and evolution of cardiopathy in experimental Chagas' disease after treatment with immunosuppressive and trypanocidal drugs. Cabeza Meckert PM; Chambó JG; Laguens RP Medicina (B Aires); 1988; 48(1):7-11. PubMed ID: 3063916 [No Abstract] [Full Text] [Related]
13. Experimental chronic Chagas' disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens. Pontes-de-Carvalho L; Santana CC; Soares MB; Oliveira GG; Cunha-Neto E; Ribeiro-dos-Santos R J Autoimmun; 2002 Mar; 18(2):131-8. PubMed ID: 11908945 [TBL] [Abstract][Full Text] [Related]
15. Infection characteristics of an Ecuadorian Trypanosoma cruzi strain with reduced virulence. Rowland E; Luo H; McCormick T J Parasitol; 1995 Feb; 81(1):123-6. PubMed ID: 7876970 [TBL] [Abstract][Full Text] [Related]
16. Antibodies against the carboxyl-terminal end of the Trypanosoma cruzi ribosomal P proteins are pathogenic. López Bergami P; Scaglione J; Levin MJ FASEB J; 2001 Dec; 15(14):2602-12. PubMed ID: 11726536 [TBL] [Abstract][Full Text] [Related]
17. The complement system and the inflammatory response in experimental Chagas' disease. Irulegui I; Yamashiro EH; Castilho EA; de Brito T Rev Inst Med Trop Sao Paulo; 1982; 24(6):349-52. PubMed ID: 6820705 [No Abstract] [Full Text] [Related]
18. Analysis of the presence of Trypanosoma cruzi in the heart tissue of three patients with chronic Chagas' heart disease. Elias FE; Vigliano CA; Laguens RP; Levin MJ; Berek C Am J Trop Med Hyg; 2003 Feb; 68(2):242-7. PubMed ID: 12641419 [TBL] [Abstract][Full Text] [Related]
19. Timing of expression of inflammatory mediators in skeletal muscles from mice acutely infected with the RA strain of Trypanosoma cruzi. Cutrullis RA; Postan M; Petray PB; Corral RS Pathobiology; 2009; 76(4):170-80. PubMed ID: 19571606 [TBL] [Abstract][Full Text] [Related]